Jeremy H. Toyn
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Computational Drug Discovery Methods, Fungal and yeast genetics research, Cholinesterase and Neurodegenerative Diseases, Microtubule and mitosis dynamics
Most-Cited Works
- → Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable γ-Secretase Inhibitor(2010)184 cited
- → Saccharomyces cerevisiae Is Capable of de Novo Pantothenic Acid Biosynthesis Involving a Novel Pathway of β-Alanine Production from Spermine(2001)175 cited
- → P40SDB25, a putative CDK inhibitor, has a role in the M/G1 transition in Saccharomyces cerevisiae.(1994)141 cited
- → A counterselection for the tryptophan pathway in yeast: 5-fluoroanthranilic acid resistance(2000)131 cited
- → The Dbf2 and Dbf20 protein kinases of budding yeast are activated after the metaphase to anaphase cell cycle transition.(1994)129 cited
- → The Swi5 Transcription Factor of Saccharomyces cerevisiae Has a Role in Exit From Mitosis Through Induction of the cdk-Inhibitor Sic1 in Telophase(1997)114 cited
- → A Bub2p-dependent spindle checkpoint pathway regulates the Dbf2p kinase in budding yeast(1999)111 cited
- → DBF2 Protein Kinase Binds to and Acts through the Cell Cycle-Regulated MOB1 Protein(1998)108 cited
- → In vivo and in vitro analysis of ptl1, a yeast ts mutant with a membrane-associated defect in protein translocation.(1988)79 cited
- → Specialization of Function Among Aldehyde Dehydrogenases: The ALD2 and ALD3 Genes Are Required for β-Alanine Biosynthesis in Saccharomyces cerevisiae(2003)78 cited